The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Optum to Cut 92 Jobs in California Amid Oxnard Closure

Optum is laying off 92 employees in California, the company disclosed in regulatory documents filed June 1, according to Becker's Hospital Review. The bulk of the cuts, 80 positions, stem from the closure of a management services organization in Oxnard. The remaining affected roles are spread across clinic locations in Los Angeles.

The move is part of a broader reshaping of Optum, the health services arm of UnitedHealth Group that has grown into one of the largest employers of physicians in the country. Optum has spent years acquiring medical groups and building out care-delivery operations, and the Oxnard shutdown shows that not every local footprint survives the integration.

For employees and patients in affected California markets, the practical effect is fewer local administrative and clinic jobs. For the industry, it is another data point on how aggressively payer-owned care organizations are pruning operations to control costs as UnitedHealth faces pressure on margins and scrutiny over its sprawling reach.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.